Insel Gruppe AG
- Country
- 🇨🇭Switzerland
- Ownership
- Private
- Established
- 2016-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- https://www.inselgruppe.ch
Status Telemetry for Cochlear Implantations
- Conditions
- Sensorineural Hearing Loss
- Interventions
- Device: STOPDevice: MAESTRO
- First Posted Date
- 2024-01-25
- Last Posted Date
- 2024-01-29
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 20
- Registration Number
- NCT06223724
- Locations
- 🇨🇭
Inselspital, Bern University Hospital Department of ENT, Head and Neck Surgery, Bern, Switzerland
GLEAM: Noninvasive Glucose Measurement Using Impedance Tomography
- Conditions
- Diabetes Mellitus
- Interventions
- Other: Controlled euglycemia, hypoglycemia and hyperglycemia
- First Posted Date
- 2024-01-25
- Last Posted Date
- 2024-05-02
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 16
- Registration Number
- NCT06223204
- Locations
- 🇨🇭
Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Bern, Switzerland
BrainAgeMS - a Comparative Study of Brain Aging in Healthy and Patients With Multiple Sclerosis
- Conditions
- Multiple Sclerosis
- First Posted Date
- 2024-01-24
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 200
- Registration Number
- NCT06221631
- Locations
- 🇨🇭
Inselspital Bern, Bern, Switzerland
Early Life Intervention in Pediatrics Supported by E-health
- Conditions
- AdiposityChildhood ObesityNon-communicable DiseaseAdolescent ObesityBehavior, EatingLife StyleBehavior, Health
- Interventions
- Behavioral: Life-Style app
- First Posted Date
- 2024-01-17
- Last Posted Date
- 2024-03-20
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 148
- Registration Number
- NCT06208345
- Locations
- 🇨🇭
Department of Paediatrics, Inselspital, Bern University Hospital, Bern, Switzerland
The International PERForator ANeurysm Registry (PERFAN)
- Conditions
- Aneurysm, Brain
- First Posted Date
- 2024-01-03
- Last Posted Date
- 2024-01-03
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 300
- Registration Number
- NCT06189014
- Locations
- 🇨🇭
Institute of Diagnostic and Interventional Neuroradiology, Inselspital Bern, Bern, Switzerland
Histological Validation of dGEMRIC Indices as a Quantitative Biomarker for Cartilage Damage in the Hip Joint
- Conditions
- Osteoarthritis, HipCartilage Damage
- First Posted Date
- 2023-12-29
- Last Posted Date
- 2024-01-11
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 25
- Registration Number
- NCT06185036
- Locations
- 🇨🇭
University Hospital of Bern (Inselspital), Bern, Switzerland
Point-of-care Measurement of the Antifibrinolytic Activity of Tranexamic Acid in Cardiac Surgery
- Conditions
- Antifibrinolytic Agents
- Interventions
- Drug: Tranexamic acid bolus 10 mg/kgDrug: Tranexamic acid bolus 20 mg/kgDrug: Tranexamic acid bolus 1 mg/kgDrug: Tranexamic acid continuous infusion of 1 mg/kg/h in the low dose group
- First Posted Date
- 2023-11-13
- Last Posted Date
- 2024-03-08
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 322
- Registration Number
- NCT06128330
- Locations
- 🇨🇭
Dpt. Anesthesiology and pain Medicine, Berne, Switzerland
Prospective Assessment Project of AirwaY Management-related Incidents in Adult Anaesthesia Care PAPAYA III
- Conditions
- Adverse EventsAirway Complication of Anesthesia
- First Posted Date
- 2023-11-03
- Last Posted Date
- 2024-05-09
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 40000
- Registration Number
- NCT06117176
- Locations
- 🇩🇪
Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
🇩🇪Deutsches Herzzentrum der Charité and Charité, Berlin, Germany
🇨🇭CHUV Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Indapamide and Chlorthalidone to Reduce Urine Supersaturation for Kidney Stone Prevention
- Conditions
- Kidney Stone
- Interventions
- First Posted Date
- 2023-11-01
- Last Posted Date
- 2025-02-19
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 99
- Registration Number
- NCT06111885
- Locations
- 🇨🇭
Inselspital, Department of Nephrology and Hypertension, Bern, Switzerland
Discovery of New Cancer in the 1-year Follow-up After Ischemic Stroke in Patients at Risk: The INVISIBLE-1 Study
- Conditions
- Embolic Stroke of Undetermined SourceOccult CancerIschemic StrokeD-dimerCancer-related StrokeParaneoplastic Coagulopathy
- First Posted Date
- 2023-10-25
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 370
- Registration Number
- NCT06100718
- Locations
- 🇨🇭
Dept, of Neurology, Inselspital, University of Bern, Bern, Switzerland
🇨🇭Dept. of Neurology, Centre Hospital Universitaire Vaudois, Lausanne, Vaud, Switzerland
🇨🇭Dept. of Neurology, Universitätsspital Basel, Basel, Switzerland